NEW ORLEANS, Sept. 23, 2025 /PRNewswire/ -- QuickTake Health has announced its commitment to the Centers for Medicare & Medicaid Services…
New Center strengthens Healthsperien's role as a hub for applied research, data-driven analysis, and policy strategy—bringing world-class expertise to support…
Peer-reviewed analysis reveals the power of proactive navigation to improve outcomes and reduce costs SEATTLE, Sept. 23, 2025 /PRNewswire/ --…
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in…
Launch coincides with the Healthcare 2030 Summit in Washington, DC, bringing together top government officials, industry leaders, and patient advocates…
With addition of Fidelis Care and MetroPlusHealth, Elektra Health now available to over 95% of women insured through commercial, Medicare…
Inmazeb® (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense,…
Rethink Impact leads investment round as company targets expansion to 30+ states by end of 2026 WASHINGTON, DC / ACCESS…
New Identity Positions Organization to Lead the Future of Proactive, Technology-Enabled Care PHILADELPHIA, Sept. 17, 2025 /PRNewswire/ -- The Medical…
NEW YORK, Sept. 17, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global digital…